Marianne Luyendijk

Marianne Luyendijk is a Visiting Professor at the Erasmus School of Health Policy & Management, Erasmus University Rotterdam. Her work focuses on Health Technology Assessment (HTA) and Cost-Effectiveness Analysis within Breast Cancer and Acute Care domains.

• University: Erasmus University Rotterdam
• School: Erasmus School of Health Policy & Management
• Department: Health Technology Assessment (HTA)
• Academic Rank: Visiting Professor

Luyendijk's research explores the intersection of health policy, medical economics, and patient-centered care. She investigates cost-effectiveness of therapies, task redistribution in acute care, and policy implementation for advanced treatments like CDK4/6 inhibitors. Her studies span oncology, emergency medicine, and health systems, emphasizing personalized treatment strategies and equitable resource allocation.

Recent publications highlight her focus on Breast Cancer (both early and metastatic stages), pharmacoeconomics, and interdisciplinary healthcare dynamics. She employs systematic reviews, cross-sectional studies, and policy analyses to evaluate health technology adoption, regulatory frameworks, and clinical decision-making.

• Research Outputs: 11 total (10 articles, 1 report)
• Key Areas: Cost-Effectiveness, HTA, Breast Cancer, Emergency Care
• Collaborations: International partnerships across 9 countries